A. Stephens

A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group Trial.

H. Cárdenes, C. Johnson, P. Helft, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of vorinostat, a histone deacetylase inhibitor to restore the hormone sensitivity to the anti-estrogen tamoxifen in patients with advanced breast cancer having failed prior aromatase inhibitor therapy

P. Munster, E. Biçaku, D. Marchion, 2008 .

Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study.

C. Yiannoutsos, L. Cripe, D. Vaena, 2004, Leukemia research.

A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer: A Hoosier Oncology Group Study

Cynthia S. Johnson, Menggang Yu, H. Cárdenes, 2011, American journal of clinical oncology.

A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113

N. Hanna, J. Patel, G. Masters, 2017, Cancer.

Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.

G. Hutchins, L. Einhorn, G. Hutchins, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.